1 Prourocare Medical Inc. Receivables Turnover Ratio (PUMD), from the third quarter 2013 to the third quarter 2012 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Competitors, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Prourocare Medical Inc. (PUMD)

Sector • Healthcare Industry • Medical Laboratories

Industry • Medical Laboratories

Sector • Healthcare

Prourocare Medical Accounts Receivables Turnover Ratio from the third quarter 2013 to the third quarter 2012

Quarterly Results, Trends, Rankings, Statistics

According to Prourocare Medical Inc. Balance Sheet, in the third quarter 2013, company has not reported any Accounts receivable.
See Prourocare Medical Inc. Balance Sheet

If we take a look into Healthcare sector Prourocare Medical Inc. achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Prourocare Medical Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PUMD Receivables Turnover Ratio	(Sep 30 2013) III. Quarter	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	-	-	-	-	-
PUMD's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

PUMD Company Profile • Back to PUMD Efficiency Comparisons • Compare PUMD Receivables Turnover Ratio to its Competitors

Financial Statements
Prourocare Medical's Accounts Receivable	$ 0 Millions	Visit PUMD's Balance sheet
Prourocare Medical's Sales TTM	$ 0 Millions	Visit PUMD's Income Statement
Sources of PUMD's Revenues		Visit PUMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PUMD's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PUMD's Growth Rates	PUMD's Roa	PUMD's Inventory Turnover Ratio	PUMD's Dividend Comparisons
PUMD's Profitability Ratios	PUMD's Roi	PUMD's Asset Turnover Ratio	PUMD's Dividend Growth
PUMD's Valuation Ratios	PUMD's Roe	PUMD's Financial Strength Ratios	PUMD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Sep 30 2013

Receivable at quarter ending Sep 30 2013

Date modified: 2026-09-08T15:07:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.